Back
4D Molecular Therapeutics Stock Price Chart
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Sell
45
FDMT
4D Molecular Therapeutics
Last Price:
$4.37
Seasonality Move:
-0.89%
7 Day Trial
ALL ACCESS PASS
$
7
One Tool. Personalized Setups.
Try it here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
4D Molecular Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.97 | Buy |
| 20-day SMA: | 4.14 | Buy |
| 50-day SMA: | 3.7 | Buy |
| 200-day SMA: | 6.05 | Sell |
| 8-day EMA: | 4 | Buy |
| 20-day EMA: | 4 | Buy |
| 50-day EMA: | 3.88 | Buy |
| 200-day EMA: | 6.92 | Sell |
4D Molecular Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 54.29 | Buy |
| Chaikin Money Flow: | 723564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.69 - 4.37) | Buy |
| Bollinger Bands (100): | (3.1 - 4.62) | Buy |
4D Molecular Therapeutics Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
-
4D Molecular Therapeutics share price is 4.15 while FDMT 8-day simple moving average is 3.97, which is a Buy signal.
-
The stock price of FDMT is 4.15 while 4D Molecular Therapeutics 20-day SMA is 4.14, which makes it a Buy.
-
4D Molecular Therapeutics 50-day simple moving average is 3.70 while FDMT share price is 4.15, making it a Buy technically.
-
FDMT stock price is 4.15 and 4D Molecular Therapeutics 200-day simple moving average is 6.05, creating a Sell signal.
FDMT Technical Analysis vs Fundamental Analysis
Sell
45
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a SellThe current 4D Molecular Therapeutics [FDMT] share price is $4.15. The Score for FDMT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
192.2M
Price in USD:
4.15
Share Volume:
858.2K
4D Molecular Therapeutics 52-Week Range
52-Week High:
28.93
52-Week Low:
2.24
Sell
45
4D Molecular Therapeutics (FDMT)
is a Sell
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?The 4D Molecular Therapeutics stock price is 4.15 USD today.
-
Will FDMT stock go up or go down?4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is 4D Molecular Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
-
4D Molecular Therapeutics share price is 4.15 while FDMT 8-day exponential moving average is 4.00, which is a Buy signal.
-
The stock price of FDMT is 4.15 while 4D Molecular Therapeutics 20-day EMA is 4.00, which makes it a Buy.
-
4D Molecular Therapeutics 50-day exponential moving average is 3.88 while FDMT share price is 4.15, making it a Buy technically.
-
FDMT stock price is 4.15 and 4D Molecular Therapeutics 200-day simple moving average is 6.92, creating a Sell signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.26 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.32 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
-
FDMT Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting 4D Molecular Therapeutics is a Buy
-
4D Molecular Therapeutics Relative Strength Index (RSI) is 54.29, which suggest 4D Molecular Therapeutics is overbought
-
The Bollinger Bands (25) for 4D Molecular Therapeutics is (3.69 - 4.37), which suggest 4D Molecular Therapeutics is a Buy
-
The Bollinger Bands (100) for 4D Molecular Therapeutics is (3.1 - 4.62), which suggest 4D Molecular Therapeutics is a Buy
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.